These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 17250462)
21. Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review. Tol J; Punt CJ Clin Ther; 2010 Mar; 32(3):437-53. PubMed ID: 20399983 [TBL] [Abstract][Full Text] [Related]
22. Cetuximab: an IgG(1) monoclonal antibody for the treatment of epidermal growth factor receptor-expressing tumours. Humblet Y Expert Opin Pharmacother; 2004 Jul; 5(7):1621-33. PubMed ID: 15212612 [TBL] [Abstract][Full Text] [Related]
23. Cetuximab: in the treatment of metastatic colorectal cancer. Reynolds NA; Wagstaff AJ Drugs; 2004; 64(1):109-18; discussion 119-121. PubMed ID: 14723561 [TBL] [Abstract][Full Text] [Related]
25. Antiangiogenesis drug promising for metastatic colorectal cancer. McCarthy M Lancet; 2003 Jun; 361(9373):1959. PubMed ID: 12801743 [No Abstract] [Full Text] [Related]
26. Epidermal growth factor receptor expression discrepancies in metastatic colorectal cancer patients treated with cetuximab plus irinotecan-based chemotherapy refractory to irinotecan and oxaliplatin. Han HS; Chang HJ; Hong YS; Kim SY; Lee KS; Jung KH Dis Colon Rectum; 2009 Jun; 52(6):1144-51; discussion 1152-3. PubMed ID: 19581859 [TBL] [Abstract][Full Text] [Related]
27. The role of targeted therapy in the treatment of colorectal cancer. Goldberg RM; Hurwitz HI; Fuchs CS Clin Adv Hematol Oncol; 2006 Aug; 4(8 Suppl 17):1-10; quiz 11-2. PubMed ID: 17139241 [TBL] [Abstract][Full Text] [Related]
28. The role of epidermal growth factor receptor-targeted antibody therapy in previously treated colorectal cancer. Watkins D; Cunningham D Clin Colorectal Cancer; 2007 Oct; 6 Suppl 2():S47-52. PubMed ID: 18021487 [TBL] [Abstract][Full Text] [Related]
29. Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer. Köhne CH; Lenz HJ Oncologist; 2009 May; 14(5):478-88. PubMed ID: 19411318 [TBL] [Abstract][Full Text] [Related]
30. Cetuximab in the treatment of colorectal cancer. Ciardiello F; De Vita F; Orditura M; Comunale D; Galizia G Future Oncol; 2005 Apr; 1(2):173-81. PubMed ID: 16555987 [TBL] [Abstract][Full Text] [Related]
31. Synergy between cetuximab and chemotherapy in tumors of the gastrointestinal tract. Mahtani RL; Macdonald JS Oncologist; 2008 Jan; 13(1):39-50. PubMed ID: 18245011 [TBL] [Abstract][Full Text] [Related]
33. Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach? Fakih M Expert Rev Anticancer Ther; 2008 Sep; 8(9):1471-80. PubMed ID: 18759698 [TBL] [Abstract][Full Text] [Related]
34. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. Cunningham D; Humblet Y; Siena S; Khayat D; Bleiberg H; Santoro A; Bets D; Mueser M; Harstrick A; Verslype C; Chau I; Van Cutsem E N Engl J Med; 2004 Jul; 351(4):337-45. PubMed ID: 15269313 [TBL] [Abstract][Full Text] [Related]
35. [Cetuximab for patients with metastatic colorectal cancer-from the result of recent clinical trials]. Ariyama H; Kusaba H; Baba E Gan To Kagaku Ryoho; 2010 May; 37(5):782-6. PubMed ID: 20495306 [TBL] [Abstract][Full Text] [Related]
36. Cetuximab plus irinotecan in refractory colorectal cancer patients. Gil Delgado M; Spano JP; Khayat D Expert Rev Anticancer Ther; 2007 Apr; 7(4):407-13. PubMed ID: 17428161 [TBL] [Abstract][Full Text] [Related]
37. Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability. Lévi F; Karaboué A; Gorden L; Innominato PF; Saffroy R; Giacchetti S; Hauteville D; Guettier C; Adam R; Bouchahda M Cancer Chemother Pharmacol; 2011 Feb; 67(2):339-48. PubMed ID: 20401611 [TBL] [Abstract][Full Text] [Related]
38. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer. Wong SF Clin Ther; 2005 Jun; 27(6):684-94. PubMed ID: 16117976 [TBL] [Abstract][Full Text] [Related]
39. Targeted therapy in advanced colorectal cancer: more data, more questions. Ochenduszko SL; Krzemieniecki K Anticancer Drugs; 2010 Sep; 21(8):737-48. PubMed ID: 20631611 [TBL] [Abstract][Full Text] [Related]
40. Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer. Wen F; Li Q World J Gastroenterol; 2016 Jun; 22(23):5332-41. PubMed ID: 27340349 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]